-transparent.png){kind=logo}
Plasma concentrations of imipramine and three of its metabolites were determined in children 6 to 15 years of age who received imipramine for treatment of nocturnal enuresis. In 14 patients with reliable data the reduction in wet nights after beginning drug therapy had no apparent relationship to either imipramine concentration alone or imipramine combined with its metabolites. This finding may be related to the relatively low drug concentrations in this group of patients, a high placebo response rate, or noncompliance with the prescribed dosage regimen. Determining plasma imipramine concentrations during treatment for enuresis has questionable value as an aid to improve clinical response. This practice may occasionally be justified when avoidance of toxicity is a major concern.
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
January 1989,
Pharmacological research,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
May 1963,
Activitas nervosa superior,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
June 1982,
Pediatrics,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
March 1969,
Hospital (Rio de Janeiro, Brazil),
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
September 1968,
Canadian Medical Association journal,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
March 1963,
The American journal of psychiatry,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
November 1979,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
January 1971,
Nordisk medicin,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
July 1990,
Ugeskrift for laeger,
C L DeVane, and
R D Walker, and
W P Sawyer, and
J A Wilson
January 1974,
JAMA,
